S
Stefan Borgwardt
Chair of Psychiatry and Psychotherapy at the University of Lübeck
Key Impact
Researches neurofunctional mechanisms of innovative treatments like cannabinoids and psychedelics for psychosis and depression.
Background & Research
Stefan Borgwardt is a prominent German psychiatrist whose research utilizes structural and functional neuroimaging to understand the effects of psychoactive drugs on the brain. His team explores the early phases of psychosis and evaluates the efficacy of cannabinoids and psychedelics in treating major depression and schizophrenia, integrating genetic and computational modeling into clinical care.
Focus Areas
NeuroimagingPsychosisCannabinoidsDepression